Body Composition and Psychosocial Factors in ICI-Treated Cancer Patients
Recruiting now
Conditions studied: Cancer, Psychosocial Functioning, Treatment Side Effects, Cachexia
In brief
Evaluation of the effects of body composition, psychosocial factors, and drug-related problems on clinical progression (such as toxicity, treatment response, and quality of life) in cancer patients treated with immune checkpoint inhibitors
Key facts
- Study ID
- NCT07130981
- Run by
- Hacettepe University
- People needed
- 200
- Starts
- 2025-09-01
- Expected to finish
- 2026-01-01
- Last updated by the study team
- 2025-08-24
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Aged 18 years or older
- Having undergone a CT scan (at the L3 level) prior to treatment
- No severe mental disorder and able to communicate effectively
- Provided written informed consent
You may not qualify if…
- Did not provide written informed consent
- Patients deemed unsuitable by the physician
Where it is running
- Hacettepe University Faculty of Pharmacy, Department of Clinical Pharmacy — Ankara, Altındağ, Turkey (Türkiye) (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.